NO20033773L - Polyamidderivater med antibakteriell, antisopp- eller antitumor-aktivitet - Google Patents
Polyamidderivater med antibakteriell, antisopp- eller antitumor-aktivitetInfo
- Publication number
- NO20033773L NO20033773L NO20033773A NO20033773A NO20033773L NO 20033773 L NO20033773 L NO 20033773L NO 20033773 A NO20033773 A NO 20033773A NO 20033773 A NO20033773 A NO 20033773A NO 20033773 L NO20033773 L NO 20033773L
- Authority
- NO
- Norway
- Prior art keywords
- fungal
- antibacterial
- tumor activity
- polyamide derivatives
- polyamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34379601P | 2001-12-26 | 2001-12-26 | |
US34382901P | 2001-12-26 | 2001-12-26 | |
PCT/US2002/041087 WO2003057212A1 (en) | 2001-12-26 | 2002-12-24 | Polyamide derivatives possessing antibacterial, antifungal or antitumor activity |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20033773D0 NO20033773D0 (no) | 2003-08-25 |
NO20033773L true NO20033773L (no) | 2003-10-23 |
Family
ID=26993629
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20033773A NO20033773L (no) | 2001-12-26 | 2003-08-25 | Polyamidderivater med antibakteriell, antisopp- eller antitumor-aktivitet |
Country Status (6)
Country | Link |
---|---|
US (1) | US7064218B2 (no) |
AU (1) | AU2002364209A1 (no) |
BR (1) | BR0207583A (no) |
NO (1) | NO20033773L (no) |
TW (1) | TW200306815A (no) |
WO (1) | WO2003057212A1 (no) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITTO20010633A1 (it) * | 2001-07-02 | 2003-01-02 | Univ Ferrara | Nuovo impiego di poliammidi eterocicliche e benzoeterocicliche strutturalmente correlate all'antibiotico naturale distamicina a. |
US20070123531A1 (en) * | 2003-05-02 | 2007-05-31 | Elan Pharmaceuticals, Inc. | 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
CA2524274A1 (en) * | 2003-05-02 | 2004-11-18 | Elan Pharmaceuticals, Inc. | 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
ES2314418T3 (es) * | 2003-05-02 | 2009-03-16 | Elan Pharmaceuticals, Inc. | Derivados de amidas del acido 4-bromo-5-(2-clorobenzoilamino)-1h-pirazol-3-carboxicilico y compuestos relacionados como antagonistas del receptor b1 de bradiquinina para el tratamiento de enfermedades inflamatorias. |
WO2006068760A2 (en) | 2004-11-19 | 2006-06-29 | The Regents Of The University Of California | Anti-inflammatory pyrazolopyrimidines |
US7585868B2 (en) | 2006-04-04 | 2009-09-08 | The Regents Of The University Of California | Substituted pyrazolo[3,4-D]pyrimidines as kinase antagonists |
US20110160232A1 (en) | 2007-10-04 | 2011-06-30 | Pingda Ren | Certain chemical entities and therapeutic uses thereof |
US8193182B2 (en) | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
WO2009088990A1 (en) | 2008-01-04 | 2009-07-16 | Intellikine, Inc. | Certain chemical entities, compositions and methods |
WO2009114874A2 (en) | 2008-03-14 | 2009-09-17 | Intellikine, Inc. | Benzothiazole kinase inhibitors and methods of use |
US8637542B2 (en) * | 2008-03-14 | 2014-01-28 | Intellikine, Inc. | Kinase inhibitors and methods of use |
WO2010006072A2 (en) | 2008-07-08 | 2010-01-14 | The Regents Of The University Of California | Mtor modulators and uses thereof |
CN102124009B (zh) | 2008-07-08 | 2014-07-23 | 因特利凯公司 | 激酶抑制剂及其使用方法 |
US8273900B2 (en) | 2008-08-07 | 2012-09-25 | Novartis Ag | Organic compounds |
WO2010036380A1 (en) | 2008-09-26 | 2010-04-01 | Intellikine, Inc. | Heterocyclic kinase inhibitors |
DK2358720T3 (en) | 2008-10-16 | 2016-06-06 | Univ California | Heteroarylkinaseinhibitorer fused-ring |
US8476282B2 (en) | 2008-11-03 | 2013-07-02 | Intellikine Llc | Benzoxazole kinase inhibitors and methods of use |
WO2010129816A2 (en) | 2009-05-07 | 2010-11-11 | Intellikine, Inc. | Heterocyclic compounds and uses thereof |
WO2011047384A2 (en) | 2009-10-16 | 2011-04-21 | The Regents Of The University Of California | Methods of inhibiting ire1 |
JP2013508397A (ja) * | 2009-10-22 | 2013-03-07 | ポリメディックス・インコーポレーテッド | 高分子化合物の調製方法 |
UY32940A (es) * | 2009-10-27 | 2011-05-31 | Bayer Cropscience Ag | Amidas sustituidas con halogenoalquilo como insecticidas y acaricidas |
WO2011146882A1 (en) | 2010-05-21 | 2011-11-24 | Intellikine, Inc. | Chemical compounds, compositions and methods for kinase modulation |
EP2637669A4 (en) | 2010-11-10 | 2014-04-02 | Infinity Pharmaceuticals Inc | Heterocyclic compounds and their use |
NZ612909A (en) | 2011-01-10 | 2015-09-25 | Infinity Pharmaceuticals Inc | Processes for preparing isoquinolinones and solid forms of isoquinolinones |
AR085397A1 (es) | 2011-02-23 | 2013-09-25 | Intellikine Inc | Combinacion de inhibidores de quinasa y sus usos |
US8969363B2 (en) | 2011-07-19 | 2015-03-03 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
TWI565709B (zh) | 2011-07-19 | 2017-01-11 | 英菲尼提製藥股份有限公司 | 雜環化合物及其用途 |
AR091790A1 (es) | 2011-08-29 | 2015-03-04 | Infinity Pharmaceuticals Inc | Derivados de isoquinolin-1-ona y sus usos |
JP6342805B2 (ja) | 2011-09-02 | 2018-06-13 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 置換ピラゾロ[3,4−d]ピリミジンおよびその用途 |
EP2602248A1 (en) | 2011-12-05 | 2013-06-12 | University Of Leicester | Novel pyrrole compounds |
US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
US8921426B2 (en) | 2012-04-18 | 2014-12-30 | International Business Machines Corporation | Cationic bis-urea compounds as effective antimicrobial agents |
US8828998B2 (en) | 2012-06-25 | 2014-09-09 | Infinity Pharmaceuticals, Inc. | Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors |
SG11201502331RA (en) | 2012-09-26 | 2015-04-29 | Univ California | Modulation of ire1 |
US9481667B2 (en) | 2013-03-15 | 2016-11-01 | Infinity Pharmaceuticals, Inc. | Salts and solid forms of isoquinolinones and composition comprising and methods of using the same |
GB201309932D0 (en) * | 2013-06-04 | 2013-07-17 | Univ Leicester | Novel pyrrole derivative |
US9751888B2 (en) | 2013-10-04 | 2017-09-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
EA201690713A1 (ru) | 2013-10-04 | 2016-08-31 | Инфинити Фармасьютикалз, Инк. | Гетероциклические соединения и их применения |
CA2943075C (en) | 2014-03-19 | 2023-02-28 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders |
WO2015160975A2 (en) | 2014-04-16 | 2015-10-22 | Infinity Pharmaceuticals, Inc. | Combination therapies |
US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
NZ740616A (en) | 2015-09-14 | 2023-05-26 | Infinity Pharmaceuticals Inc | Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same |
WO2017161116A1 (en) | 2016-03-17 | 2017-09-21 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors |
WO2017214269A1 (en) | 2016-06-08 | 2017-12-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
CN109640999A (zh) | 2016-06-24 | 2019-04-16 | 无限药品股份有限公司 | 组合疗法 |
CN106832175B (zh) * | 2017-02-17 | 2019-10-18 | 华南理工大学 | 一种基于咔唑衍生物的双羟基荧光扩链剂及其制备与应用 |
CN111641046B (zh) * | 2020-05-07 | 2021-07-06 | 宁波大学 | 一种微波段宽带圆二色性手性吸波器 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4107288A (en) | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
CA1308516C (en) | 1987-07-06 | 1992-10-06 | J. William Lown | Oligopeptide anticancer and antiviral agents |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
CA2145418A1 (en) * | 1992-09-29 | 1994-04-14 | John S. Patton | Pulmonary delivery of active fragments of parathyroid hormone |
WO1995004732A1 (en) | 1993-08-06 | 1995-02-16 | Synphar Laboratories, Inc. | Oligopeptide antiretroviral agents |
US5770736A (en) * | 1994-06-21 | 1998-06-23 | Northeastern University | Reagents for cleavage or crosslinking of biomolecules using nondiffusible reactive intermediates |
US5502068A (en) | 1995-01-31 | 1996-03-26 | Synphar Laboratories, Inc. | Cyclopropylpyrroloindole-oligopeptide anticancer agents |
JP4061819B2 (ja) * | 2000-05-12 | 2008-03-19 | 独立行政法人科学技術振興機構 | インターストランドクロスリンク剤の合成方法 |
KR20030011371A (ko) * | 2000-06-27 | 2003-02-07 | 진랩스 테크놀러지스, 인크. | 항세균, 항진균 또는 항암 활성을 갖는 신규 화합물 |
-
2002
- 2002-12-24 US US10/328,710 patent/US7064218B2/en not_active Expired - Lifetime
- 2002-12-24 BR BR0207583-0A patent/BR0207583A/pt not_active Application Discontinuation
- 2002-12-24 AU AU2002364209A patent/AU2002364209A1/en not_active Abandoned
- 2002-12-24 WO PCT/US2002/041087 patent/WO2003057212A1/en not_active Application Discontinuation
- 2002-12-26 TW TW091137474A patent/TW200306815A/zh unknown
-
2003
- 2003-08-25 NO NO20033773A patent/NO20033773L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20033773D0 (no) | 2003-08-25 |
WO2003057212A1 (en) | 2003-07-17 |
US7064218B2 (en) | 2006-06-20 |
BR0207583A (pt) | 2004-04-27 |
AU2002364209A1 (en) | 2003-07-24 |
TW200306815A (en) | 2003-12-01 |
US20030212113A1 (en) | 2003-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20033773D0 (no) | Polyamidderivater med antibakteriell, antisopp- eller antitumor-aktivitet | |
FR15C0068I2 (fr) | Derives de diamine | |
DE60202270D1 (de) | 4,5-dihydro-1h-pyrazolderivate mit cb1-antagonistischer wirkung | |
NO20014128D0 (no) | Camptothecinderivater som har antitumoraktivitet | |
NO20025720D0 (no) | Nye forbindelser med antibakteriell, soppdrepende eller antitumoraktivitet | |
NO20035634L (no) | Diamin-derivater | |
DE60214428D1 (de) | 1, 4-dihydro-1, 4-diphenylpyridin-derivate | |
ITTO20010940A0 (it) | ,,sedia,, | |
DK1281310T3 (da) | Höstmaskine med hastighedsstyring | |
PT1406628E (pt) | Derivados de tera-hidroquinolina | |
DE50213548D1 (de) | Substituierte 2-carba-3,5-dicyano-4-aryl-6-aminopylektive liganden | |
DK1423071T3 (da) | Absorberende artikel, der har åbninger i det absorberende legeme | |
BR0201919B1 (pt) | colheitadeira. | |
ATE397610T1 (de) | Avermectinmonosaccharidderivate mit pestiziden eigenschaften | |
DK1373290T3 (da) | Pesticidale spinosynderivater | |
NO20042980L (no) | 3,4-dihydro-1H-isokinolin-2-yl-derivater | |
ATE376988T1 (de) | Dihalo-allyloxy-phenol-derivate mit pestizid- aktivität | |
DE60117900D1 (de) | Phytosphingosinderivate mit Antitumorwirkung | |
FR2834289B1 (fr) | Derives de benzothiazole-4,7-diones et benzooxazole-4,7- diones, leur preparation et leurs applications therapeutiques | |
DE50309025D1 (de) | Inhärent vernetzbare polyamide | |
FR2823089B1 (fr) | Cintre coulissant extensible | |
ES1050769Y (es) | Galleta perfeccionada. | |
DK1373216T3 (da) | 4,5-dihydro-1H-pyrazolderivater med CB1-antagonistisk aktivitet | |
ES1048424Y (es) | Colgador perfeccionado. | |
ES1054003Y (es) | Pantalon perfeccionado. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |